4
Changes in Ownership
BeOne Medicines Ltd. Filed Acc 0001628280-25-040540
President and COO sold 89,794 shares at an average $304.56 ($27,347,635)
- President and COO acquired 89,794 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wu Xiaobin President and COO | 2025-08-13 | Option exercise 10b5-1 | +22,773 | $174.43 | $3,972,294 | 22,773 | D: show line 1 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Option exercise 10b5-1 | +27,085 | $155.68 | $4,216,593 | 49,858 | D: show line 2 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Sale 10b5-1 | −8,900 | $300.33 | $2,672,962 | 40,958 | D: show line 3 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Sale 10b5-1 | −4,500 | $301.49 | $1,356,703 | 36,458 | D: show line 4 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Sale 10b5-1 | −5,800 | $302.45 | $1,754,194 | 30,658 | D: show line 5 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Sale 10b5-1 | −3,517 | $303.54 | $1,067,564 | 27,141 | D: show line 6 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Sale 10b5-1 | −7,359 | $304.37 | $2,239,887 | 19,782 | D: show line 7 in the form |
| Wu Xiaobin President and COO | 2025-08-13 | Sale 10b5-1 | −528 | $305.59 | $161,352 | 19,254 | D: show line 8 in the form |
| Open-market sales · 89,794 sh · avg $304.56 · $27,347,635 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wu Xiaobin President and COO | 2025-08-13 | Option exercise · Share Option (Right to Buy) 10b5-1 | −296,049 | 0 | D: show line 21 in the form | ||
| Wu Xiaobin President and COO | 2025-08-13 | Option exercise · Share Option (Right to Buy) 10b5-1 | −352,105 | 709,709 | D: show line 22 in the form | ||
| Wu Xiaobin President and COO | 2025-08-14 | Option exercise · Share Option (Right to Buy) 10b5-1 | −399,828 | 309,881 | D: show line 23 in the form | ||
| Wu Xiaobin President and COO | 2025-08-14 | Option exercise · Share Option (Right to Buy) 10b5-1 | −119,340 | 358,046 | D: show line 24 in the form |
Loading xslF345X05/wk-form4_1755290412.xml…